138 related articles for article (PubMed ID: 30409962)
1. Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression.
Ding H; Wen Z; Sun G
Med Sci Monit; 2018 Nov; 24():8015-8021. PubMed ID: 30409962
[TBL] [Abstract][Full Text] [Related]
2. XPD could suppress growth of HepG2.2.15 and down-regulate the expression of hepatitis B virus x protein through P53 pathway.
Ding H; Xu JJ; Huang Y; Du FT; Zhang JX
Biochem Biophys Res Commun; 2012 Mar; 419(4):761-7. PubMed ID: 22387547
[TBL] [Abstract][Full Text] [Related]
3. The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells.
Wang HY; Xiong GF; Zhang JX; Xu H; Guo WH; Xu JJ; Xiong XY
Med Oncol; 2012 Mar; 29(1):161-7. PubMed ID: 21264535
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of regulation of hepatoma cell cycle by XPD/P44 subcomplex : an in vitro experiment].
Wang HY; Xiong GF; Wu BL; Zhang JX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1997-2001. PubMed ID: 19062744
[TBL] [Abstract][Full Text] [Related]
5. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway.
He Y; Tao W; Shang C; Qi C; Ji D; Lu W; Chen G
Int J Exp Pathol; 2021 Jun; 102(3):157-162. PubMed ID: 33993564
[TBL] [Abstract][Full Text] [Related]
6. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
7. XPD Functions as a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells.
Zheng JF; Li LL; Lu J; Yan K; Guo WH; Zhang JX
Med Sci Monit; 2015 May; 21():1562-8. PubMed ID: 26031757
[TBL] [Abstract][Full Text] [Related]
8. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
9. ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway.
Zhang G; Guan Y; Zhao Y; van der Straaten T; Xiao S; Xue P; Zhu G; Liu Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Chem Biol Interact; 2017 Feb; 263():55-65. PubMed ID: 28027876
[TBL] [Abstract][Full Text] [Related]
10. Role of Xeroderma Pigmentosum Group D in Cell Cycle and Apoptosis in Cutaneous Squamous Cell Carcinoma A431 Cells.
Liu OG; Xiong XY; Li CM; Zhou XS; Li SS
Med Sci Monit; 2018 Jan; 24():453-460. PubMed ID: 29362353
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced apoptosis is delayed and reduced in XPD lymphoblastoid cell lines: possible role of TFIIH in p53-mediated apoptotic cell death.
Robles AI; Wang XW; Harris CC
Oncogene; 1999 Aug; 18(33):4681-8. PubMed ID: 10467415
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma Pigmentosum Group D (XPD) Inhibits the Proliferation Cycle of Vascular Smooth Muscle Cell (VSMC) by Activating Glycogen Synthase Kinase 3β (GSK3β).
Li Q; Liao C; Xu W; Li G; Hong K; Cheng X; Li J
Med Sci Monit; 2018 Aug; 24():5951-5959. PubMed ID: 30146633
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.
Wan Z; Pan H; Liu S; Zhu J; Qi W; Fu K; Zhao T; Liang J
Oncol Rep; 2015 Mar; 33(3):1560-6. PubMed ID: 25607597
[TBL] [Abstract][Full Text] [Related]
14. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
[TBL] [Abstract][Full Text] [Related]
15. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
16. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
17. Mcl-1 as a potential therapeutic target for human hepatocelluar carcinoma.
Yu Q; Liu ZY; Chen Q; Lin JS
J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):494-500. PubMed ID: 27465322
[TBL] [Abstract][Full Text] [Related]
18. Effect of β -catenin siRNA on proliferation and apoptosis of hepatoma cell line SMMC-7721 and HepG-2.
Liyan W; Xun S; Xiangwei M
Hepatogastroenterology; 2011; 58(110-111):1757-64. PubMed ID: 22086699
[TBL] [Abstract][Full Text] [Related]
19. RACK1 Silencing Induces Cell Apoptosis and Inhibits Cell Proliferation in Hepatocellular Carcinoma MHCC97-H Cells.
Zou YH; Li XD; Zhang QH; Liu DZ
Pathol Oncol Res; 2018 Jan; 24(1):101-107. PubMed ID: 28396991
[TBL] [Abstract][Full Text] [Related]
20. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
